XTalks
MARCH 29, 2021
The results did not differ based on fast or slow caffeine metabolism genotype. They also believe caffeine could potentially disrupt fetal stress hormones, putting infants at risk for rapid weight gain after birth and for chronic conditions such as obesity, heart disease and diabetes later on in life.
XTalks
SEPTEMBER 15, 2020
In addition to the vaccine, the company is also developing an investigational drug called Remygen for the regeneration of endogenous insulin production and to improve hormonal response to hypoglycemia; trials to test the treatment are currently ongoing in patients that have been living with type 1 diabetes for more than five years.
The Pharma Data
DECEMBER 9, 2020
The creation of Overland isn’t the only exciting thing happening for international life sciences companies and organizations. announced a research collaboration to develop hormone receptor antagonist (GHRA) peptides as potential treatments for acromegaly, a rare but serious endocrine disorder with significant unmet medical need.
Expert insights. Personalized for you.
98 
Let's personalize your content